Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹1.4 CrAdmitted-Finance 4TH FLOOR B WING ZYDUS CORPORATE PARK S G HIGHWAY NEAR VAISHNODEVI CIRCLE AHMEDABAD GUJARAT 382481 | AHMADABAD | GUJARAT | 382481 | ₹1.4 Cr | L1 | Admitted-Finance |
| 2 | L2₹6.0 Cr+₹4.6 Cr (337.1%)Admitted-Finance 146 B 166 A UNIT NO 7 8 9 8TH FLOOR R CITY OFFICE R CITY MALL LAL BAHADUR SHASTRI MARG GHATKOPAR MUMBAI MAHARASHTRA 400086 | MUMBAI SUBURBAN | MAHARASHTRA | 400086 | ₹6.0 Cr+₹4.6 Cr (337.1%) | L2 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Roche Products (India) Pvt Ltd L2 | zydus lifesciences limited L1 |
|---|---|---|---|---|---|
| 1.00 | PVMS No 011054, Inj Trastuzumab Emtansine (TDM-1) vial of 100mg | 509 | Vial | 5,37,91,120 ₹6,02,46,054.4 | 1,23,06,515.47 ₹1,37,83,297.53 Lowest |
Tender Value
Refer Docs
Closing Date
9 Sept 2025, 10:00 amClosed
DDG (Prov), O/o DGAFMS
DDG(Prov) O/o DGAFMS Ministry of Defence 5th Floor, A Block, Defence Offices Complex Africa Avenue New Delhi 110023
Supply of PVMS No 011054, Inj Trastuzumab Emtansine (TDM-1) vial of 100mg
2025_ARMY_725164_1
RC/25-26/80
Open Tender
Drugs and Pharmaceutical Products
Buy
30 days
New Delhi
As per RFP
6 documents required · 6 mandatory
₹0
Exempted
9 Oct 2025
8 Aug 2025
9 Sept 2025
8 Aug 2025
9 Sept 2025
22 Aug 2025
8 Aug 2025 - 22 Aug 2025
PVMS No 011054, Inj Trastuzumab Emtansine (TDM-1) vial of 100mg
Roche Products (India) Pvt Ltd (BID ID -3412640)
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .